A recombinant pantothecin bacterium with filamentous cell morphology, its construction method and application

By overexpressing the slmA and sulA genes in Panthocytica camel, changing the morphology of the bacteria into filament, solving the problem of separation of extracellular polysaccharides and bacteria, achieving efficient separation and improvement of production efficiency, and being suitable for a variety of industrial applications.

CN118638711BActive Publication Date: 2024-11-01NANJING TECH UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411129189.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-16
Publication Date
2024-11-01
Estimated Expiration
2044-08-16

AI Technical Summary

Technical Problem

The prior art is difficult to effectively separate extracellular polysaccharides from bacteria during the fermentation of Pansygoidae, resulting in complexity and high cost of separation.

Method used

By overexpressing the slmA and sulA genes in Panthocytica, the bacterial morphology is changed to filamentous shape, the isolation process is simplified, and the recombinant strain is constructed using expression vectors and electroconversion technology to achieve efficient separation of extracellular polysaccharides.

Benefits of technology

It significantly reduces the separation cost and time, improves production efficiency, and simplifies downstream processing steps, and is suitable for Panthocytic Camel and other microorganisms that need to improve the separation efficiency of extracellular polysaccharides.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118638711B_ABST
    Figure CN118638711B_ABST
Patent Text Reader

Abstract

The present invention discloses a recombinant Pantotrichum sutchuenensis with filamentous cell morphology and a construction method and application thereof. Pantoea alhagi Overexpression in XK11 slmA and sulA The present invention is achieved by Pantoea alhagi Cell morphology regulatory genes in XK11 slmA and sulA The induced expression was constructed into a recombinant strain, which significantly increased the cell length of the recombinant strain, compared with the original strain Pantoea camelliae. Pantoea alhagi The length of XK11 cells increased by 15-20 times. The recombinant Pantoea camelliae can achieve more efficient bacterial cell collection, thereby simplifying the downstream processing process and reducing downstream processing costs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of microbial engineering, specifically to a recombinant pantothecin spp. with filamentous cell morphology, its construction method, and its application. Background Technology

[0002] Pantotheca acuminata (Camelthorn Pantotheca) Pantoea alhagi XK-11 is a Gram-negative bacterium widely distributed in the natural environment, attracting widespread attention due to its ability to produce abundant extracellular polysaccharides (EPS). EPS has various industrial applications, including as a thickener, stabilizer, and carrier material in biomedicine. However, the EPS produced by *U. cambodiana* during fermentation faces numerous challenges in downstream separation and purification, primarily because the bacterial cells and EPS are mixed together, making effective separation difficult. Existing technologies typically rely on traditional centrifugation and filtration techniques, which struggle to address the mixing issue between EPS and bacterial cells, thus increasing the complexity and cost of the separation process. Therefore, promoting EPS separation through filamentous transformation of *U. cambodiana* cell morphology is one measure to reduce the complexity and cost of the separation process.

[0003] CN117965413A discloses a recombinant *Panthera philoxeroides* strain with elongated cell morphology, its construction method, and its applications. This is achieved by knocking out… minc Genetic manipulation yielded recombinant Pantotheca acuminata cells that were more elongated than the original strain XK-11, with a length two to several times that of the original strain. These cells were well-suited for the preparation of Pantotheca acuminata polysaccharides, facilitating separation and improving the efficiency of downstream processing.

[0004] Therefore, without affecting the cell growth and polysaccharide yield of the precursor, cell morphology can be better controlled for its application in downstream processing. Summary of the Invention

[0005] Purpose of the invention: The technical problem to be solved by the present invention is to address the shortcomings of the prior art by providing a recombinant pantotheca cumingii with filamentous cell morphology, its construction method and application, thereby promoting the separation of extracellular polysaccharides, significantly improving the downstream separation efficiency of pantotheca cumingii extracellular polysaccharides, reducing separation costs and improving production efficiency.

[0006] To address the aforementioned technical problems, this invention discloses a recombinant *Panthera cambogia* strain with filamentous cell morphology, wherein the recombinant *Panthera cambogia* strain is simultaneously overexpressed in the original strain *Panthera cambogia*. slmA Genes and sulA Genes were obtained, wherein the starting strain was *Panthera cambogia*. Pantoea alhagi XK 11, with accession number CGMCC NO.15526, has detailed information published in CN111808777A. The strain will be abbreviated as XK 11 below.P.alhagi XK 11. (The following is a separate, unrelated sentence:) slmA The nucleotide sequence of the gene is shown in SEQ ID NO:3; sulA The nucleotide sequence of the gene is shown in SEQ ID NO:4.

[0007] The recombinant *Panthera philoxeroides* strain comprises an expression vector, which contains a resistance gene promoter—the KanR resistance gene. araBAD promoter, slmA Genes and sulA The resistance gene promoter - the nucleotide sequence of the KanR resistance gene is shown in SEQ ID NO:1; araBAD The nucleotide sequence of the promoter is shown in SEQ ID NO:2; araBAD There are two promoters on the expression vector, located at [locations to be filled in]. slmA Genes and sulA The 5' end of the gene.

[0008] This invention further proposes a method for constructing the above-mentioned recombinant *Panthera philoxeroides*, comprising the following steps:

[0009] (1) Preparation of the starting strain Pantotheca camelii Pantoea alhagi XK 11 competent cells;

[0010] (2) Construct an expression vector, wherein the plasmid of the expression vector is inserted with slmA Genes and sulA The gene is transferred into the prepared XK-11 competent cells of the starting strain by electroporation using an electroporator to obtain a recombinant strain containing the expression vector; preferably, the plasmid of the expression vector is the pBAD plasmid.

[0011] (3) The above recombinant strains were induced by L-arabinose to obtain simultaneous overexpression slmA and sulA Pantotheca acuminata, a recombinant strain of two genes.

[0012] In step (2), the expression vector is kanamycin resistant. The expression vector is electroporated into the starting strain under the conditions of voltage of 12kV~14kV and time of 3ms~5ms. Then, the recombinant strain containing the expression vector is finally obtained under the screening of kanamycin resistance.

[0013] In one embodiment, the expression vector is pBADF1. slmA-sulA It is constructed using the following method:

[0014] 1) Using the genome of the originating strain as a template, primers (pBAD) were used to... -slmA-F / pBAD -slmA- R and pBAD- sulA -F / pBAD- sulA -R) PCR amplification obtained slmA Gene fragments and sulA The gene fragment was extracted, and the resistance gene AmpR of the original pBAD / His plasmid was modified into KanR, so that the plasmid had kanamycin resistance. The modified empty vector plasmid was named pBADH.

[0015] 2) Using the empty vector plasmid pBADH as a template, the vector frame 1 was obtained by double digestion at the restriction sites using SacI and HindIII restriction enzymes.

[0016] 3) Take the result from step 1) slmA Genes and sulA The genes were ligated to vector framework 1 above using the ligase Exnase II to obtain expression vectors pBADF for two different gene expression. slmA pBADF sulA That is, the expression vector pBADF is a plasmid into which a foreign DNA is inserted for expression in the empty plasmid pBADH;

[0017] 4) Using the expression vector pBADF slmA Using a template, vector frame 2 was obtained by cutting the restriction enzyme sites, and then expressed using the pBADF expression vector. sulA Using a template, a single-stranded PCR product was obtained through PCR and product purification. araBAD-sulA Nucleotide fragments, the araBAD- sulA Nucleotide fragments are those containing araBAD promoters and sulA Nucleotide fragments of genes; the aforementioned araBAD-sulA The nucleotide sequence of the fragment is SEQ ID NO: 7;

[0018] 5) Connect the above-mentioned carrier frame 2 with araBAD-sulA Nucleotide fragments were ligated using the ligase Exnase II to obtain the expression vector pBADF1. slmA-sulA .

[0019] In step (3), before adding L-arabinose, the recombinant strain carrying the expression vector is first inoculated into kanamycin-resistant medium and cultured. The OD of the bacterial culture is... 600 After culturing to a growth rate of 0.4-0.6, L-arabinose is added for induction.

[0020] Preferably, the working concentration of the L-arabinose is 10 mM to 20 mM.

[0021] Meanwhile, based on the above construction method, primers (pBAD) were used. -mreB- F / pBAD -mreB- R) PCR amplification obtained mreB Gene fragments, wherein, the aforementioned mreB The nucleotide sequence of the gene is shown in SEQ ID NO:5. It is then ligated with vector frame 1 as in step 3) to obtain the expression vector pBADF. mreB ; Using the method in step 4), the plasmid pBADF is... mreB Using a template, through primers (KAN) -mreB- F, KAN -mreB- R) PCR amplification and PCR product purification to obtain a single PCR product. araBAD-mreB Nucleotide fragments, the araBAD-mreB Nucleotide fragments are those containing araBAD promoters and mreB Nucleotide fragments of genes; the aforementioned araBAD- mreB The nucleotide sequence of the fragment is SEQ ID NO:9; (same as step 5) the above-mentioned vector framework 2 and vector framework 3 are combined with... araBAD- mreB Nucleotide fragments were ligated using the ligase Exnase II to obtain the expression vector pBADF1. slmA-mreB and expression vector pBADF1 sulA-mreB .

[0022] This invention further proposes the application of the above-mentioned recombinant Pantotheca cambogia in the fermentation preparation of Pantotheca cambogia extracellular polysaccharides.

[0023] Specifically, in application, the cells are separated by centrifugation after fermentation, with a centrifugal force ≥5000 g.

[0024] Beneficial Effects: The extracellular polysaccharide-producing strain constructed in this invention significantly reduces the mixing degree between the bacterial cells and extracellular polysaccharides during fermentation through filamentous cell morphology, making the separation process of extracellular polysaccharides simpler and more efficient. In existing technologies, complex centrifugation and filtration processes lead to high separation costs. This invention simplifies the separation steps by changing the physical morphology, thereby significantly reducing production costs. Due to the simplified and efficient separation process, downstream processing time is significantly shortened, improving overall production efficiency. This invention is not only applicable to *Ureaplasma camelida*, but can also be extended to other microorganisms requiring improved extracellular polysaccharide separation efficiency, showing broad industrial application prospects. It has enormous application potential in the food, pharmaceutical, and cosmetic industries. Attached Figure Description

[0025] The present invention will be further described in detail below with reference to the accompanying drawings and specific embodiments, and the advantages of the present invention in the above and / or other aspects will become clearer.

[0026] Figure 1 The structure diagram of the expression plasmid pBADF;

[0027] Figure 2 The structure diagram of expression plasmid pBADF1;

[0028] Figure 3 Recombinant strain with filamentous cell morphology P.alhagi XK 11-pBADF SulA (WT / sul A), P.alhagi XK 11-pBADF SlmA (WT / slm A), P.alhagi XK 11-pBADF1 slmA-sulA (WT / slm A -sul A) and empty vector starting strain P.alhagi Cell morphology observation of XK 11-pBADH (WT / pBADF);

[0029] Figure 4 Recombinant strain P.alhagi XK 11-pBADF mreB (WT / mreB ), P.alhagi XK 11-pBADF1 sulA-mreB (WT / sul A -mreB ), P.alhagi XK 11- pBADF1 slmA-mreB Empty starting strain P.alhagi Cell morphology observation of XK11-pBADH (WT / pBADF);

[0030] Figure 5 Recombinant strains that overexpress morphological regulatory genes P.alhagi XK 11-pBADF / pBADF1 and empty vector starting strain P.alhagi Growth curve of XK 11-pBADH;

[0031] Figure 6 For simultaneous overexpression slmA and sulA recombinant strains P.alhagi XK 11-pBADF1 slmA-sulA and empty vector starting strain P.alhagi The state of the XK 11-pBADH shake-flask fermentation broth after centrifugation at ≥5000 g for 20 min; the control group was... P.alhagi XK 11-pBADH, experimental group P.alhagiXK 11-pBADF1 slmA-sulA。 Detailed Implementation

[0032] The list of primers used in the following examples is shown in Table 1.

[0033] Table 1 Primers used in this application

[0034]

[0035] Example 1: Construction of expression vector pBADF.

[0036] The expression vector contains conventional expression elements and a resistance gene promoter—the kanamycin resistance gene (KanR). araBAD promoter ( araBAD promoter) and slmA or sulA-mreB Nucleotide fragments.

[0037] The nucleotide fragment of the resistance gene promoter—the kanamycin resistance gene (KanR)—is shown in SEQ ID NO: 1:

[0038] TTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGTATGAGCCATATTCAACGGGAAACGTCTTGCTCTAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAACTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAA。

[0039] The araBAD promoter ( araBAD promoter) nucleotide fragment is as shown in SEQ ID NO: 2:

[0040] AAAGCCATGACAAAAACGCGTAACAAAAGTGTCTATAATCACGGCAGAAAAGTCCACATTGATTATTTGCACGGCGTCACACTTTGCTATGCCATAGCATTTTTATCCATAAGATTAGCGGATCCTACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCAT。

[0041] The slmA nucleotide fragment of the gene is as shown in SEQ ID NO: 3: ATGGCAGAAAAAAAGAGCGCGAAAAGGAATCGTCGCGATGAAATCCTGCAGGCTCTGGCGCAAATGCTGGAATCCAGCGACGGGAGTCAGCGTATTACTACCGCTAAGCTGGCCGCTACGGTAGGCGTCTCCGAAGCTGCGCTTTACCGTCATTTTCCCAGTAAAACGCGCATGTTTGATAGCCTGATCGAGTTTATTGAAGATAGCCTGATCACCCGCATCAACGCGATTACTGAAAGATGAAAAAGAGACCATGACGCGTTTGCATATGATCGTGCAGCTAATTTTAGGTTTTGGCGAGCTTAACCCTGGTCTGACGCGTATTCCTACCGGTCATGCGCTGATGTTCGAACAGGATCGTTTGCAGGGCCGCATTAACCAGCTTTTCGAGCGTATCGAAGCGCAGCTGAGGCAGGTGATGCGCGAGCGCAAAATGCGTGAAGGGCAAGGCTTCGCCACCGACGAAACGCTGCTTGCCAGCCAGCTGCTGGCTTTTTGTGAAGGTATGCTGTCGCGCTTTGTGCGCTCAGAGTTCCGCTATCTGCCTACACAGGAGTTTGACGTACGCTGGCCGCTGTTAGCAGCGCAGCTGGTATAG。

[0042] The sulAThe nucleotide fragment of the gene is as shown in SEQ ID NO: 4: ATGCGTACTCATTTTACTGAAGTCTTCTGTTGCTCGTTCTGCTTTGCCTGGCCATTCTCGCGTTGCCGTATCGCCGGTCTTAACAACCGGTTGGATCAGCGAGCTAAGCTATAGCGAAGCTCAGCCAGGGCTAACGCAGCTGTTACTCCTGCCGCTATTACAGCAGTTGGGTACGCAGTCGCGCTGGCAGCTCTGGCTAACGCCGCCGCAAAAGATCAGCCGCCAGTGGCTTAAGGCTTCAGGACTGCCGCTGAATAAGATGATGCAGCTCCCTTATCATCAAGCGTTCAGTACGGTTGAGGCGATGATAAAAGCGTTGCAAACAGGGAATTACAGTGTGGTTTTGGGCTGGTTTGCTAATGATATCAGCGAAAACGATCGTCGTCGGCTTGAAGCAGCAGCGTCCGCAGGACAGGCTCTTGGACTCATAATGCGACCCCAAACTGGCGCTACTTGTCCCAGCGGACAAAAAAACCGGCTGAAAATTCATCAACTTTGTATCATTAA。

[0043] The said mreB

[0044] First, using the genome of the originating strain as a template, primers pBAD were used to... -slmA- F / pBAD -slmA- R, pBAD- sulA -F / pBAD- sulA -R and pBAD -mreB- F / pBAD -mreB- R was amplified by PCR to obtain slmA , sulA , mreB Gene fragments; at the same time, the resistance gene and promoters (AmpR and AmpR promoter) of the original pBAD / His plasmid were modified into KanR and KanR promoters, and the modified empty vector plasmid was named pBADH.

[0045] Based on this, using the empty vector plasmid pBADH as a template, the vector frame 1 was obtained by double digestion at the restriction sites using SacI and HindIII restriction enzymes.

[0046] Then, the PCR product was purified to obtain slmA, sulA , mreB The gene fragments were ligated to the vector framework 1 described above using Exnase II to obtain the expression vector pBADF carrying the target gene. slmA pBADF sulA and pBADF mreB These are collectively referred to as expression vector pBADF. The expression vector pBADF is a plasmid into which a foreign DNA molecule is inserted for expression. The expression vector pBADF is as follows: Figure 1 As shown.

[0047] Example 2: Construction of expression vector pBADF1.

[0048] The expression vector pBADF1 contains conventional expression elements, the kanamycin resistance gene (KanR), and the kanamycin resistance gene promoter (KanR promoter). araBAD promoter ( araBAD The promoter is the same as the expression vector pBADF mentioned above, except that the target gene contained at the cloning site is a two-gene fragment, such as... slmA-sulA Nucleotide fragments slmA- mreB Nucleotide fragments and sulA-mreB Nucleotide fragments.

[0049] The aforementioned slmA-sulA Nucleotide fragments contain slmA Gene fragments, araBAD -sulA Nucleotide fragments sulA Gene fragments; the aforementioned slmA-sulA The nucleotide fragment is shown in SEQ ID NO: 6; araBAD - sulA The nucleotide fragment is shown in SEQ ID NO: 7.

[0050] Specifically, slmA-sulA The nucleotide sequence of the fragment, SEQ ID NO: 6, is as follows:

[0051]

[0052] araBAD-sulA The fragment nucleotide sequence SEQ ID NO: 7 is as follows:

[0053] AAAGCCATGACAAAAACGCGTAACAAAAGTGTCTATAATCACGGCAGAAAAGTCCACATTGATTATTTGCACGGCGTCACACTTTGCTATGCCATAGCATTTTTATCCATAAGATTAGCGGATCCTACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATACCCGTTTTTTGGGCTAACAGGAGGAATTAACCATGGGGGGTTCTCATCATCATCATCATCATGGTATGGCTAGCATGACTGGTGGACAGCAAATGGGTCGGGATCTGTACGACGATGACGATAAGGATCGATGGGGATCCGAGCTCATGCGTACTCATTTACTGAAGTCTTCTGTTGCTCGTTCTGCTTTGCCTGGCCATTCTCGCGTTGCCGTATCGCCGGTCTTAACAACCGGTTGGATCAGCGAGCTAAGCTATAGCGAAGCTCAGCCAGGGCTAACGCAGCTGTTACTCCTGCCGCTATTACAGCAGTTGGGTACGCAGTCGCGCTGGCAGCTCTGGCTAACGCCGCCGCAAAAGATCAGCCGCCAGTGGCTTAAGGCTTCAGGACTGCCGCTGAATAAGATGATGCAGCTCCCTTATCATCAAGCGTTCAGTACGGTTGAGGCGATGATAAAAGCGTTGCAAACAGGGAATTACAGTGTGGTTTTGGGCTGGTTTGCTAATGATATCAGCGAAAACGATCGTCGTCGGCTTGAAGCAGCAGCGTCCGCAGGACAGGCTCTTGGACTCATAATGCGACCCCAAACTGGCGCTACTTGTCCCAGCGGACAAAAAAACCGGCTGAAAATTCACTCAACTTTGTATCATTAA

[0054] The said slmA-mreB nucleotide fragment contains slmA gene fragment, araBAD - mreBNucleotide fragments mreB Gene fragments; the aforementioned slmA-mreB The nucleotide fragment is shown in SEQ ID NO: 8; araBAD - mreB The nucleotide fragment is shown in SEQ ID NO: 9.

[0055] Specifically, slmA-mreB The nucleotide sequence of the fragment, SEQ ID NO: 8, is as follows:

[0056]

[0057] araBAD - mreB The nucleotide sequence of the fragment, SEQ ID NO: 9, is as follows:

[0058]

[0059] The aforementioned sulA-mreB Nucleotide fragments contain sulA Gene fragments, araBAD - mreB Nucleotide fragments mreB Gene fragments; the aforementioned sulA-mreB The nucleotide fragment is shown in SEQ ID NO: 10;

[0060] Specifically, sulA-mreB The nucleotide sequence of the fragment, SEQ ID NO: 10, is as follows:

[0061]

[0062] Using the construction method as described in Example 1, with the above-mentioned contents slmA plasmid pBADF slmA and containing sulA The gene plasmid pBADF sulA Using XmnI as a template, the restriction sites were cut with the XmnI restriction enzyme to obtain vector frame 2 and vector frame 3. Then, using the enzyme containing... sulA The gene plasmid pBADF sulA and containing mreB The gene plasmid pBADF mreB Using KAN as a template, through primers -sulA- F / KAN -sulA- R and KAN -mreB- F / KAN -mreB- R was used for PCR amplification and PCR product purification. The PCR product was then purified again to obtain a single... araBAD-sulA And a araBAD-mreB Nucleotide fragments;

[0063] The aforementioned araBAD-sulA Nucleotide fragments are those containing araBAD promoters and sulA Nucleotide fragments of a gene;

[0064] The aforementioned araBAD-mreB Nucleotide fragments are those containing araBAD promoters and mreB Nucleotide fragments of a gene.

[0065] Finally, the aforementioned carrier frame 2 and araBAD-sulA (or araBAD- Nucleotide fragments of mreB are ligated using the ligase Exnase II to obtain the expression vector pBADF1. slmA-sulA pBADF1 slmA-mreB pBADF1 sulA-mreB Collectively referred to as pBADF1, the expression vector pBADF1 is a plasmid for expression by inserting a foreign DNA strand into the expression vector pBADF. The structure of the expression vector pBADF1 is as follows: Figure 2 As shown, three different expression vectors were obtained.

[0066] Example 3: Construction of recombinant pantothecin spp.

[0067] First, competent cells of the starting strain XK-11 were prepared by inoculating the starting strain XK-11 into 5 mL of LB medium and culturing overnight to obtain a primary seed culture. Then, the primary seed culture was inoculated at a rate of 1% into 100 mL of LB medium and cultured for 2-3 hours (OD). 600(Approximately 0.4-0.6), then incubate the bacterial culture on ice for 10 minutes, aliquot into pre-chilled 50mL centrifuge tubes, centrifuge at 4℃, 4000rpm for 5 minutes, discard the supernatant, resuspend in pre-chilled ddH2O and add to a final volume of 30mL, mix by inverting, centrifuge at 4℃, 4000rpm for 5 minutes, discard the supernatant, resuspend in ddH2O containing 10% glycerol and add to a final volume of 30mL, mix by inverting, centrifuge at 4℃, 4000rpm for 5 minutes, and finally use 1-2 XK-11 competent cells were obtained by resuspending the bacterial sludge in ddH2O containing 10% glycerol. The constructed expression vector was then introduced into the starting strain XK-11 via electroporation. The volume ratio of the expression vector to competent cells was 0.5 / 10 to 1 / 10. The mixture was introduced into the starting strain XK-11 under conditions of 12-14 kV and 3-5 ms. Recombinant strains were obtained after kanamycin resistance screening. These recombinant strains carried pBADF... slmA pBADF sulA pBADF mreB pBADF1 slmA-sulA pBADF1 slmA-mreB pBADF1 sulA-mreB The XK-11 strain expressing the vector was used. The recombinant strain was inoculated into kanamycin-resistant medium and cultured. The OD of the bacterial culture was... 600 The cells were cultured to a density of 0.4-0.6, and then induced with L-arabinose at a working concentration of 10 mM-20 mM. Finally, recombinant pantotheca camelidii with filamentous cell morphology was obtained.

[0068] Example 4: Morphological observation of recombinant Pantotheca acuminata.

[0069] After inducing the recombinant *Panthera philoxeroides* strain with 0.2% L-arabinose for 24 h, 2 mL of bacterial culture was collected and bacterial cells were collected by centrifugation at 5000 g for 2 min. The cells were washed three times with ddH2O, and the supernatant was discarded after centrifugation. 2.5% glutaraldehyde was added to a 2 mL centrifuge tube, and the sample was fixed overnight at 4 °C. Subsequently, the cells were washed three times with phosphate buffer, and after adding 1% osmium tetroxide for 4–6 h, they were washed again with phosphate buffer. A gradient ethanol dehydration process was then performed, followed by freeze-drying of the cell samples as described above. Electron microscopy samples were prepared, and cell morphology was observed using scanning electron microscopy. The cell morphology of the strain is shown in the figure below. Figure 3 As shown. By Figure 3 It can be seen that overexpression in *Panthera philoxeroides* is observed. sulA, slmA The gene enables *Panthera philoxeroides* to become filamentous, increasing cell length by 10-15 times compared to the original strain, and is simultaneously overexpressed in *Panthera philoxeroides*. sulA and slmAThe degree of gene filamentation is more pronounced, with cell length increasing 15-20 times compared to the original strain. Figure 4 overexpression mreB The gene tends to have a round cell morphology and is overexpressed. sulA and mreB Genes and simultaneous overexpression slmA and mreB Genes cause cell morphology to increase 1-1.5 times or tend towards roundness. In summary, the optimal combination for filamentous cell morphology is simultaneous overexpression. sulA and slmA Gene.

[0070] Example 5: Morphological and growth analysis of recombinant Pantotheca acuminata.

[0071] The recombinant *Plasmodium styracifolium* strain activated and cultured on solid plates was inoculated into 10 mL of fresh LB broth and cultured overnight at 37 °C and 200 rpm to obtain the primary seed culture; P.alhagi XK 11- pBADF, P .alhagi XK 11- pBADF1 and P.alhagi XK 11 primary seed culture was inoculated at 1% into three separate 250mL shake flasks containing 50mL LB liquid medium. The flasks were incubated at 37℃ and 200rpm for 24 hours. When the OD600 value of the bacterial culture reached 0.4-0.6, L-arabinose at a working concentration of 10mM-20mM was added for induction. OD600 values ​​were measured every 2 hours from the start of inoculation for comparative analysis of growth. Figure 5 As shown, by Figure 5 Recombinant Pantotheca acuminata was observed. P.alhagi XK 11pBADF1 slmA-sulA , P.alhagi XK 11 pBADF sulA contrast P. alhagi The growth of XK 11 showed no significant difference, while other strains... P.alhagi XK 11 pBADF slma , P.alhagi XK 11 pBADF mreB , P.alhagi XK 11pBADF1 slmA-mreB , P.alhagi XK 11 pBADF1 sulA-mreB Its growth was affected.

[0072] Example 6: Fermentation preparation of recombinant camel thorn pantotheca polysaccharide.

[0073] Obtained using the same method described above. P.alhagi XK 11- pBADF1slmA-sulA and P.alhagi XK 11-pBADH primary seed culture was obtained by transferring the primary seed culture to 200 mL of LB medium at an inoculation rate of 1% to 4% and culturing at 37 ℃ and 200 rpm for 12 h.

[0074] The secondary seed culture was transferred at an inoculum rate of 4%–10% to a fermenter containing 2 L of fermentation medium (60 g / L sucrose, 10 g / L peptone, 5 g / L sodium chloride, 1 g / L dipotassium hydrogen phosphate, pH=7). Fermentation was carried out for 24 h at an aeration rate of 2–2.5 vvm and a stirring speed of 200 rpm to obtain recombinant pantothecinus camelthorn. P.alhagi XK 11-pBADF slmA-sulA Fermentation broth of polysaccharides.

[0075] Alcohol precipitation is currently the mainstream process for extracting various polysaccharides. The fermentation broth is centrifuged at 5000g for 20 min, the supernatant is collected, and 2 times the volume of the supernatant is added for precipitation with 95% ethanol. It is then centrifuged again at 5000g for 5 min, the supernatant is discarded, and the broth is dried to obtain the desired polysaccharide extract. P.alhagi XK 11-pBADF1 polysaccharide, in addition P.alhagi The fermentation preparation of XK 11 and other recombinant camel thorn pantothecin polysaccharides followed the same steps as described above. The final result was... P.alhagi XK 11- pBADF slmA-sulA The polysaccharide yield was 12.5±1 g / L, and the polysaccharide yield of the starting strain XK 11 was 11±1 g / L, with no significant difference in polysaccharide yield.

[0076] Example 7: Analysis of the isolation efficiency of *Panthera philoxeroides* filamentous strains.

[0077] Regarding the isolation efficiency analysis of *Plasmodium cambogia* filamentous strains, firstly, 20 mL of each... P.alhagi XK 11-pBADF slmA-sulA and P.alhagi The XK 11 fermentation broth was divided into 50 mL EP centrifuge tubes and centrifuged at 5000 g for 20 min. After centrifugation, the sedimentation degree of the bacterial culture in both tubes was observed. Figure 6 As shown, the control group consisted of strains. P.alhagi XK 11, the experimental group is a recombinant strain P.alhagi XK 11- pBADF slmA-sulA As shown in the figure, after centrifugation at 5000g for 20 minutes, the control strain... P.alhagi XK 11 supernatant relative to recombinant strain P.alhagi XK 11- pBADF slmA-sulAThe supernatant was relatively turbid. This indicates that the recombinant strain can achieve better cell collection, which helps improve the efficiency of downstream separation and processing.

[0078] This invention provides a method and approach for constructing filamentous cell morphology in *Panthera philoxeroides*. Many methods and approaches exist for implementing this technical solution; the above description is merely a preferred embodiment. It should be noted that those skilled in the art can make various improvements and modifications without departing from the principles of this invention, and these improvements and modifications should also be considered within the scope of protection of this invention. All components not explicitly stated in this embodiment can be implemented using existing technologies.

Claims

1. A recombinant Pantoea alpiniae with filamentous cell morphology, characterized in that: The recombinant Pantoea algina is simultaneously overexpressed in the starting strain Pantoea algina sL Genes and sulA The gene is obtained, wherein the starting strain is Pantoea alhagi XK 11, with a deposit number of CGMCC NO.15526, and the sL The nucleotide sequence of the gene is shown in SEQ ID NO:6 from position 1 to position 597; sulA The nucleotide sequence of the gene is shown in positions 314 to 820 of SEQ ID NO:

7.

2. The recombinant Pantoea acuminata according to claim 1, characterized in that The recombinant Pantoea acuminata comprises an expression vector, wherein the expression vector comprises a resistance gene promoter-KanR resistance gene, araBAD Promoter, sL Genes and sulA gene; the nucleotide sequence of the resistance gene promoter-KanR resistance gene is shown in SEQ ID NO: 1; the araBAD The nucleotide sequence of the promoter is shown in SEQ ID NO: 2; araBAD There are two promoters on the expression vector, located at sL Genes and sulA 5' end of the gene.

3. The method for constructing the recombinant Pantoea alpiniae according to claim 1 or 2, characterized in that: The steps include: (1) Preparation of the starting strain Pantoea acuminata Pantoea alhagi XK 11 competent cells; (2) constructing an expression vector, wherein the plasmid of the expression vector is inserted sL Genes and sulA Gene, the expression vector is transferred into the starting strain Pantoea acuminata prepared in step (1) by electroporation. Pantoea alhagi XK 11 competent cells to obtain a recombinant strain containing the expression vector; (3) The above recombinant strain was induced by L-arabinose to obtain simultaneous overexpression sL and sulA Recombination of two genes from Pantoea acuminata.

4. The construction method according to claim 3, characterized in that: In step (2), the expression vector has kanamycin resistance, and the expression vector is electroporated into the starting strain under the conditions of voltage of 12kv~14kv and time of 3ms~5ms, and then the recombinant strain containing the expression vector is finally obtained under the selection of kanamycin resistance.

5. The construction method according to claim 3, characterized in that: The expression vector is pBADF1 slmA-sulA , which is constructed by the following method: 1) Obtained by PCR using the genome of the starting strain as a template sL Genes and sulA Gene, and the resistance gene AmpR of the original pBAD / His plasmid was transformed into KanR, so that the plasmid has kanamycin resistance, and the transformed empty plasmid was named pBADH; 2) Using the empty plasmid pBADH as a template, double digestion was performed at the restriction site with SacI and HindIII endonucleases to obtain vector framework 1; 3) The obtained value in step 1) sL Gene and sulA The genes were connected to the above-mentioned vector framework 1 by ligase to obtain two expression vectors pBADF for different expression genes. slmA , pBADF sulA ; 4) Using expression vector pBADF slmA As a template, vector frame 2 was obtained by cutting the restriction site, and then the expression vector pBADF sulA As a template, through PCR and product purification, a araBAD-sulA Nucleotide fragment, the araBAD- sulA The nucleotide fragments contain araBAD Promoter and sulA A nucleotide fragment of a gene; araBAD-sulA The nucleotide sequence of the fragment is SEQ ID NO: 7; 5) Combine the above vector framework 2 with araBAD– sulA The nucleotide fragments were connected by ligase to obtain the expression vector pBADF1 slmA-sulA .

6. The construction method according to claim 3, characterized in that: In step (3), before adding L-arabinose, the recombinant strain carrying the expression vector is first inoculated into a kanamycin resistance medium for culture. After the bacterial solution OD600 is cultured to 0.4-0.6, L-arabinose is added for induction.

7. The construction method according to claim 3 or 5, characterized in that: The working concentration of L-arabinose is 10 mM ~ 20 mM.

8. Use of the recombinant Pantoea alpiniae according to claim 1 or 2 in fermenting and preparing Pantoea alpiniae exopolysaccharide.

9. The use according to claim 8, characterized in that: After fermentation, the bacteria were separated by centrifugation with a centrifugal force ≥ 5000 g.